Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Autologous Bedside CD19 CAR T-cell Therapy for B-ALL
ClinicalTrials.gov study NCT07277504. IPD Sharing: YES. Countries: 1. Publications: 0.
MC-19PD1 CAR-T in Relapsed or Refractory B Cell Lymphoma
ClinicalTrials.gov study NCT03932955. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
ClinicalTrials.gov study NCT06052826. IPD Sharing: Not stated. Countries: 1. Publications: 0.
To Evaluate the Safety and Efficacy of Human CD19 Targeted DASH CAR-T Cells Injection for Subjects With R/R B-ALL
ClinicalTrials.gov study NCT05651191. IPD Sharing: NO. Countries: 1. Publications: 0.
A Combination of Rituximab and Varlilumab Immunotherapy in Patients with B-cell Lymphoma
ClinicalTrials.gov study NCT03307746. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Study of U01（ssCART-19） in Patients With B-Cell Lymphoma
ClinicalTrials.gov study NCT07093073. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of iPD1 CD19 eCAR T Cells in Relapsed or Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT03208556. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Prime-boost Anti-pneumococcal Vaccination in Patients With Diffuse Large B Cell Lymphoma Treated With Rituximab
ClinicalTrials.gov study NCT04214444. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-cell NHL
ClinicalTrials.gov study NCT03283137. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+
ClinicalTrials.gov study NCT06355739. IPD Sharing: NO. Countries: 1. Publications: 0.
An Evaluation AZD2014 Alone and in Combination With Rituximab in Relapsed/Refractory Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT02752204. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
HMPL-760 in Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT05190068. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT06015880. IPD Sharing: YES. Countries: 1. Publications: 0.
B Cells in Idiopathic Nephrotic Syndrome
ClinicalTrials.gov study NCT05712369. IPD Sharing: NO. Countries: 1. Publications: 0.
Anti-CD19 FasT CAR-T Cell Therapy for B Cell NHL
ClinicalTrials.gov study NCT04638270. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bryostatin and Vincristine in B-Cell Malignancies
ClinicalTrials.gov study NCT00003166. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of CD19/CD22 Dual Targeted CAR-T Cell Therapy in R/R B-Cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT05225831. IPD Sharing: Not stated. Countries: 1. Publications: 0.
MEN1703 (SEL24) to Treat Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma (JASPIS-01)
ClinicalTrials.gov study NCT06534437. IPD Sharing: NO. Countries: 4. Publications: 0.
Design of New Personalized Therapeutic Approaches for Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT03797170. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
CD19-targeted CAR-T Cell Therapy for MRD+ B-cell Malignancies After Autologous Stem Cell Transplantation
ClinicalTrials.gov study NCT03564977. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.